Microdosimetric spread for cell-sized targets exposed to ⁶⁰Co, ¹⁹²Ir and ¹²⁵I sources.
The magnitude of the spread in specific energy deposition per cell may be a confounding factor in dose-response analysis motivating derivation of explicit data for the most common brachytherapy isotopes (125)I and (192)Ir, and for (60)Co radiation frequently used as reference in RBE studies. The aim of this study is to analyse the microdosimetric spread as given by the frequency distribution of specific energy for a range of doses imparted by (125)I, (192)Ir and (60)Co sources. An upgraded version of the Monte Carlo code PENELOPE was used for scoring energy deposition distributions in liquid water for each of the radiation qualities. Frequency distributions of specific energy were calculated according to the formalism of Kellerer and Chmelevsky. Results indicate that the magnitude of the microdosimetric spread increases with decreasing target size and decreasing energy of the radiation quality. Within the clinical relevant dose range (1 to 100 Gy), the spread does not exceed 4 % for (60)Co, 5 % for (192)Ir and 6 % for (125)I. The frequency distributions can be accurately approximated with symmetrical normal distributions at doses down to 0.2 Gy for (60)Co, 0.1 Gy for (192)Ir and 0.08 Gy for (125)I.
Department of Immunology, Genetics and Pathology, Medical Radiation Physics, Uppsala University, Akademiska Sjukhuset, Uppsala SE-75185, Sweden Fernanda.villegas-navarro@igp.uu.se.
F
F
Villegas
Department of Immunology, Genetics and Pathology, Medical Radiation Physics, Uppsala University, Akademiska Sjukhuset, Uppsala SE-75185, Sweden Elekta Instrument AB, Box 1704, Uppsala SE-75147, Sweden.
N
N
Tilly
Department of Immunology, Genetics and Pathology, Medical Radiation Physics, Uppsala University, Akademiska Sjukhuset, Uppsala SE-75185, Sweden.
A
A
Ahnesjö
D001918:Brachytherapy / Q000379:methods*; D002467:Cell Nucleus / Q000528:radiation effects*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D004781:Environmental Exposure / Q000032:analysis; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007496:Iridium Radioisotopes / Q000627:therapeutic use*; D009010:Monte Carlo Method; D011874:Radiometry / Q000379:methods*; D011879:Radiotherapy Dosage
D003037:Cobalt Radioisotopes; D007457:Iodine Radioisotopes; D007496:Iridium Radioisotopes